These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
(State of incorporation)
|
|
(IRS Employer Identification No.)
|
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
|
|
|
|
|
|
(Nasdaq Global Select Market)
|
|
|
|
☒
|
No
|
☐
|
|
|
|
☒
|
No
|
☐
|
|
|
☒
|
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐
|
|
Smaller reporting company
|
|
|
|
|
|
Emerging growth company
|
|
|
|
Yes
|
|
No
|
☒
|
|
Class
|
|
Outstanding at November 30, 2019
|
|
Common Stock - $0.01 par value
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
Certifications
|
|
||
|
|
November 30, 2019
|
|
March 2, 2019
|
||||
|
|
|
|
|
||||
|
Assets
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
Short term investment securities
|
|
|
|
|
|
||
|
Merchandise inventories
|
|
|
|
|
|
||
|
Prepaid expenses and other current assets
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Total current assets
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Long term investment securities
|
|
|
|
|
|
||
|
Property and equipment, net
|
|
|
|
|
|
||
|
Operating lease assets
|
|
|
|
—
|
|
||
|
Goodwill
|
|
|
|
|
|
||
|
Other assets
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Total assets
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Liabilities and Shareholders' Equity
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Accounts payable
|
$
|
|
|
|
$
|
|
|
|
Accrued expenses and other current liabilities
|
|
|
|
|
|
||
|
Merchandise credit and gift card liabilities
|
|
|
|
|
|
||
|
Current operating lease liabilities
|
|
|
|
—
|
|
||
|
Current income taxes payable
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Total current liabilities
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Other liabilities
|
|
|
|
|
|
||
|
Income taxes payable
|
|
|
|
|
|
||
|
Operating lease liabilities
|
|
|
|
—
|
|
||
|
Long term debt
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Total liabilities
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Shareholders' equity:
|
|
|
|
|
|
||
|
Preferred stock - $0.01 par value; authorized - 1,000 shares; no shares issued or
outstanding
|
|
|
|
|
|
||
|
Common stock - $0.01 par value; authorized - 900,000 shares; issued 344,077 and
342,582, respectively; outstanding 126,961 and 132,233 shares, respectively
|
|
|
|
|
|
||
|
Additional paid-in capital
|
|
|
|
|
|
||
|
Retained earnings
|
|
|
|
|
|
||
|
Treasury stock, at cost; 217,116 and 210,349 shares, respectively
|
(
|
)
|
|
(
|
)
|
||
|
Accumulated other comprehensive loss
|
(
|
)
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Total shareholders' equity
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Total liabilities and shareholders' equity
|
$
|
|
|
|
$
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
November 30, 2019
|
|
December 1, 2018
|
|
November 30, 2019
|
|
December 1, 2018
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net sales
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of sales
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Selling, general and administrative expenses
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Goodwill and other impairments
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Operating (loss) profit
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Interest expense, net
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
(Loss) earnings before provision for income taxes
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
(Benefit) provision for income taxes
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net (loss) earnings
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net (loss) earnings per share - Basic
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Net (loss) earnings per share - Diluted
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average shares outstanding - Basic
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Weighted average shares outstanding - Diluted
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Dividends declared per share
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
November 30, 2019
|
|
December 1, 2018
|
|
November 30, 2019
|
|
December 1, 2018
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net (loss) earnings
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||||
|
Change in temporary impairment of auction rate securities, net of taxes
|
(
|
)
|
|
|
|
|
|
|
|
|
|
||||
|
Pension adjustment, net of taxes
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
Currency translation adjustment
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income (loss)
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Comprehensive (loss) income
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three Months Ended November 30, 2019
|
|||||||||||||||||||||
|
|
Common Stock
|
Additional Paid-
in Capital
|
Retained
Earnings
|
Treasury Stock
|
Accumulated Other
Comprehensive
Loss
|
Total
|
||||||||||||||||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||||||||
|
Balance at August 31, 2019
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Net loss
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Other comprehensive income, net of tax
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Dividend declared
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Issuance of restricted shares, net
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Payment and vesting of performance stock units
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Stock-based compensation expense, net
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Repurchase of common stock, including fees
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
|
Balance at November 30, 2019
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
Nine Months Ended November 30, 2019
|
|||||||||||||||||||||
|
|
Common Stock
|
Additional Paid-
in Capital
|
Retained
Earnings
|
Treasury Stock
|
Accumulated Other
Comprehensive
Loss
|
Total
|
||||||||||||||||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||||||||
|
Balance at March 2, 2019
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Net loss
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Other comprehensive income, net of tax
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Effect of Adoption of ASU 2016-02
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Dividend declared
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Issuance of restricted shares, net
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Payment and vesting of performance stock units
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Stock-based compensation expense, net
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Repurchase of common stock, including fees
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
|
Balance at November 30, 2019
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
Three Months Ended December 1, 2018
|
|||||||||||||||||||||
|
|
Common Stock
|
Additional Paid-
in Capital
|
Retained
Earnings
|
Treasury Stock
|
Accumulated Other
Comprehensive
Loss
|
Total
|
||||||||||||||||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||||||||
|
Balance at September 1, 2018
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Net earnings
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Other comprehensive loss, net of tax
|
|
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Dividend declared
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Issuance of restricted shares, net
|
(
|
)
|
—
|
|
—
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Stock-based compensation expense, net
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Repurchase of common stock, including fees
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
|
Balance at December 1, 2018
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
Nine Months Ended December 1, 2018
|
|||||||||||||||||||||
|
|
Common Stock
|
Additional Paid-
in Capital
|
Retained
Earnings
|
Treasury Stock
|
Accumulated Other
Comprehensive
Loss
|
Total
|
||||||||||||||||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
||||||||||||||||||
|
Balance at March 3, 2018
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Net earnings
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Other comprehensive loss, net of tax
|
|
|
|
|
|
|
(
|
)
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Effect of Adoption of ASU 2014-09
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Dividend declared
|
|
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Issuance of restricted shares, net
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Payment and vesting of performance stock units
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Stock-based compensation expense, net
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Repurchase of common stock, including fees
|
|
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
|
Balance at December 1, 2018
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
|
|
Nine Months Ended
|
||||||
|
|
November 30, 2019
|
|
December 1, 2018
|
||||
|
Cash Flows from Operating Activities:
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Net (loss) earnings
|
$
|
(
|
)
|
|
$
|
|
|
|
Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
|
|
|
|
|
||
|
Goodwill and other impairments
|
|
|
|
|
|
||
|
Gain on sale of a building
|
|
|
|
(
|
)
|
||
|
Stock-based compensation
|
|
|
|
|
|
||
|
Deferred income taxes
|
(
|
)
|
|
(
|
)
|
||
|
Other
|
(
|
)
|
|
(
|
)
|
||
|
Decrease (increase) in assets:
|
|
|
|
|
|
||
|
Merchandise inventories
|
|
|
|
(
|
)
|
||
|
Trading investment securities
|
|
|
|
|
|
||
|
Other current assets
|
(
|
)
|
|
|
|
||
|
Other assets
|
(
|
)
|
|
|
|
||
|
Increase (decrease) in liabilities:
|
|
|
|
|
|
||
|
Accounts payable
|
|
|
|
|
|
||
|
Accrued expenses and other current liabilities
|
|
|
|
|
|
||
|
Merchandise credit and gift card liabilities
|
(
|
)
|
|
|
|
||
|
Income taxes payable
|
(
|
)
|
|
(
|
)
|
||
|
Operating lease assets and liabilities, net
|
|
|
|
—
|
|
||
|
Other liabilities
|
|
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Net cash provided by operating activities
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Cash Flows from Investing Activities:
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Purchase of held-to-maturity investment securities
|
(
|
)
|
|
(
|
)
|
||
|
Redemption of held-to-maturity investment securities
|
|
|
|
|
|
||
|
Capital expenditures
|
(
|
)
|
|
(
|
)
|
||
|
Proceeds from sale of a building
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Net cash provided by (used in) investing activities
|
|
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Cash Flows from Financing Activities:
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Payment of dividends
|
(
|
)
|
|
(
|
)
|
||
|
Repurchase of common stock, including fees
|
(
|
)
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Net cash used in financing activities
|
(
|
)
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Net increase in cash, cash equivalents and restricted cash
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Cash, cash equivalents and restricted cash:
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Beginning of period
|
|
|
|
|
|
||
|
End of period
|
$
|
|
|
|
$
|
|
|
|
1)
|
Basis of Presentation
|
|
•
|
Level 1 - Valuations based on quoted prices in active markets for identical instruments that the Company is able to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
|
|
•
|
Level 2 - Valuations based on quoted prices in active markets for instruments that are similar, or quoted prices in markets that are not active for identical or similar instruments, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
|
|
•
|
Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
|
|
(in millions)
|
November 30, 2019
|
|
March 2, 2019
|
||||
|
Available-for-sale securities:
|
|
|
|
|
|
||
|
Long term
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Held-to-maturity securities:
|
|
|
|
||||
|
Short term
|
|
|
|
|
|
||
|
Total investment securities
|
$
|
|
|
|
$
|
|
|
|
(in thousands)
|
Statement of Operations Location
|
Three months ended November 30, 2019
|
|
Nine months ended November 30, 2019
|
||||
|
Operating lease cost
|
Cost of sales and SG&A
|
$
|
|
|
|
$
|
|
|
|
Finance lease cost:
|
|
|
|
|
||||
|
Depreciation of property
|
SG&A
|
|
|
|
|
|
||
|
Interest on lease liabilities
|
Interest expense, net
|
|
|
|
|
|
||
|
Variable lease cost
|
Cost of sales and SG&A
|
|
|
|
|
|
||
|
Sublease income
|
SG&A
|
(
|
)
|
|
(
|
)
|
||
|
Total lease cost
|
|
$
|
|
|
|
$
|
|
|
|
(in thousands)
|
Consolidated Balance Sheet Location
|
November 30, 2019
|
||
|
Assets
|
|
|
||
|
Operating leases
|
Operating lease assets
|
$
|
|
|
|
Finance leases
|
Property and equipment, net
|
|
|
|
|
Total Lease assets
|
|
$
|
|
|
|
|
|
|
||
|
Liabilities
|
|
|
||
|
Current:
|
|
|
||
|
Operating leases
|
Current operating lease liabilities
|
$
|
|
|
|
Finance leases
|
Accrued expenses and other current liabilities
|
|
|
|
|
Noncurrent:
|
|
|
||
|
Operating leases
|
Operating lease liabilities
|
|
|
|
|
Finance leases
|
Other liabilities
|
|
|
|
|
Total lease liabilities
|
|
$
|
|
|
|
(in thousands)
|
Operating Leases
|
|
Finance Leases
|
||||
|
Fiscal Year:
|
|
|
|
||||
|
Remainder of 2019
|
$
|
|
|
|
$
|
|
|
|
2020
|
|
|
|
|
|
||
|
2021
|
|
|
|
|
|
||
|
2022
|
|
|
|
|
|
||
|
2023
|
|
|
|
|
|
||
|
Thereafter
|
|
|
|
|
|
||
|
Total lease payments
|
$
|
|
|
|
$
|
|
|
|
Less imputed interest
|
(
|
)
|
|
(
|
)
|
||
|
Present value of lease liabilities
|
$
|
|
|
|
$
|
|
|
|
|
|
November 30, 2019
|
|
|
Weighted-average remaining lease term (in years)
|
|
|
|
|
Operating leases
|
|
|
|
|
Finance leases
|
|
|
|
|
Weighted-average discount rate
|
|
|
|
|
Operating leases
|
|
|
%
|
|
Finance leases
|
|
|
%
|
|
(in thousands)
|
|
Nine months ended November 30, 2019
|
||
|
Cash paid for amounts included in the measurement of lease liabilities
|
|
|
||
|
Operating cash flows from operating leases
|
|
$
|
|
|
|
Operating cash flows from finance leases
|
|
|
|
|
|
Operating lease assets obtained in exchange for new operating lease liabilities
|
|
|
|
|
|
(in thousands)
|
Operating Leases
|
|
|
Fiscal Year:
|
|
|
|
2019
|
|
|
|
2020
|
|
|
|
2021
|
|
|
|
2022
|
|
|
|
2023
|
|
|
|
Thereafter
|
|
|
|
Total future minimum lease payments
|
|
|
|
|
Nine Months Ended
|
||||
|
Black-Scholes Valuation Assumptions (1)
|
November 30, 2019
|
|
December 1, 2018
|
||
|
Weighted Average Expected Life (in years) (2)
|
|
|
|
|
|
|
Weighted Average Expected Volatility (3)
|
|
%
|
|
|
%
|
|
Weighted Average Risk Free Interest Rates (4)
|
|
%
|
|
|
%
|
|
Expected Dividend Yield (5)
|
|
%
|
|
|
%
|
|
(Shares in thousands)
|
Number of Stock
Options
|
|
Weighted Average
Exercise Price
|
|||
|
Options outstanding, beginning of period
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
Forfeited or expired
|
(
|
)
|
|
|
|
|
|
Options outstanding, end of period
|
|
|
|
$
|
|
|
|
Options exercisable, end of period
|
|
|
|
$
|
|
|
|
(Shares in thousands)
|
Number of Restricted
Shares
|
|
Weighted Average
Grant-Date Fair
Value
|
|||
|
Unvested restricted stock, beginning of period
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
Vested
|
(
|
)
|
|
|
|
|
|
Forfeited
|
(
|
)
|
|
|
|
|
|
Unvested restricted stock, end of period
|
|
|
|
$
|
|
|
|
|
Nine Months Ended
|
|
|
Monte Carlo Simulation Assumptions
|
November 30, 2019
|
|
|
Risk Free Interest Rate
|
|
%
|
|
Expected Dividend Yield
|
|
%
|
|
Expected Volatility
|
|
%
|
|
Expected Term
|
|
|
|
(Shares in thousands)
|
Number of Performance
Stock Units
|
|
Weighted Average
Grant-Date Fair
Value
|
|||
|
Unvested performance stock units, beginning of period
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
Vested
|
(
|
)
|
|
|
|
|
|
Forfeited or performance condition adjustments
|
(
|
)
|
|
|
|
|
|
Unvested performance stock units, end of period
|
|
|
|
$
|
|
|
|
•
|
Time-vesting restricted stock units ("RSUs") consisting of the following:
|
|
◦
|
|
|
◦
|
|
|
•
|
|
|
•
|
Net sales for the
three months ended November 30, 2019
were
$2.759 billion
, a decrease of approximately
9.0%
as compared with the
three months ended December 1, 2018
. Net sales for the
nine months ended November 30, 2019
were
$8.052 billion
, a decrease of approximately
7.7%
as compared with the
nine months ended December 1, 2018
.
|
|
•
|
Comparable sales for the
three and nine months ended November 30, 2019
decreased by approximately
8.3%
and
7.2%
, respectively, as compared to a decrease of approximately
1.8%
and
1.0%
for the
three and nine months ended December
|
|
•
|
Gross profit for the
three months ended November 30, 2019
was
$913.8 million
, or
33.1%
of net sales, compared with
$1.004 billion
, or
33.1%
of net sales, for the
three months ended December 1, 2018
. Gross profit for the
nine months ended November 30, 2019
was
$2.528 billion
, or
31.4%
of net sales, compared with
$2.957 billion
, or
33.9%
of net sales, for the
nine months ended December 1, 2018
.
The decrease in the gross profit margin for the nine months ended November 30, 2019 was primarily attributable to a decrease in merchandise margin, as a result of an incremental inventory reserve for future markdowns of approximately $169.8 million related to the Company's transformation initiatives, which was an incremental charge to the actual markdowns recorded in the second and third quarters of fiscal 2019.
|
|
•
|
Selling, general and administrative expenses ("SG&A") for the
three months ended November 30, 2019
were
$931.8 million
, or
33.8%
of net sales, compared with
$954.2 million
, or
31.5%
of net sales, for the
three months ended December 1, 2018
. SG&A for the
nine months ended November 30, 2019
were
$2.705 billion
, or
33.6%
of net sales, compared with
$2.748 billion
, or
31.5%
of net sales, for the
nine months ended December 1, 2018
.
|
|
•
|
Goodwill and other impairments for the three and
nine months ended November 30, 2019
were
$11.8 million
, or
0.4%
of net sales, and
$441.4 million
or
5.5%
of net sales, respectively. There were no goodwill and other impairments in the
three and nine months ended December 1, 2018
.
|
|
•
|
Interest expense, net for the
three and nine months ended November 30, 2019
was
$17.2 million
and
$49.4 million
, respectively, compared with
$22.7 million
and
$54.0 million
, respectively, for the
three and nine months ended December 1, 2018
.
|
|
•
|
The effective tax rate for both the
three and nine months ended November 30, 2019
was
17.9%
, as compared with
9.2%
and
25.1%
, respectively, for the
three and nine months ended December 1, 2018
. For the
three and nine months ended November 30, 2019
, the effective tax rate reflects the impact of charges for goodwill and other impairments and severance costs, portions of which are non-deductible for tax purposes. The tax rates also included other discrete tax items resulting in net after tax costs of approximately
$3.5 million
and
$10.5 million
, respectively for the
three and nine months ended November 30, 2019
and net after tax benefits of approximately
$4.8 million
and
$3.2 million
for the
three and nine months ended December 1, 2018
.
|
|
•
|
For the three months ended November 30, 2019, net loss per diluted share was
$(0.31)
(
$(38.6) million
), as compared with net earnings per diluted share of
$0.18
(
$24.4 million
) for the three months ended December 1, 2018. The decrease in net earnings per diluted share for the
three months ended November 30, 2019
is the result of the decrease in net earnings due to the items described above and by the impact of the Company's repurchases of its common stock. In addition, for
|
|
(a)
|
Disclosure Controls and Procedures
|
|
(b)
|
Changes in Internal Control over Financial Reporting
|
|
Period
|
Total Number of Shares Purchased (1)
|
|
Average Price Paid per Share (2)
|
|
Total Number of
Shares Purchased as
Part of Publicly or Announced Plans Programs (1)
|
|
Approximate Dollar
Value of Shares
that May Yet Be
Purchased Under
the Plans or Programs (1)(2)
|
||||||
|
September 1, 2019 - September 28, 2019
|
3,200
|
|
|
$
|
10.58
|
|
|
3,200
|
|
|
$
|
1,238,271,869
|
|
|
September 29, 2019 - October 26, 2019
|
7,200
|
|
|
$
|
12.21
|
|
|
7,200
|
|
|
$
|
1,238,183,963
|
|
|
October 27, 2019 - November 30, 2019
|
76,700
|
|
$
|
13.54
|
|
|
76,700
|
|
$
|
1,237,145,824
|
|
||
|
Total
|
87,100
|
|
|
$
|
13.32
|
|
|
87,100
|
|
|
$
|
1,237,145,824
|
|
|
Exhibit No.
|
Exhibit
|
|
|
|
|
10.1*
|
|
|
|
|
|
10.2* **
|
|
|
|
|
|
10.3* **
|
|
|
|
|
|
10.4* **
|
|
|
|
|
|
31.1**
|
|
|
|
|
|
31.2**
|
|
|
|
|
|
32**
|
|
|
|
|
|
101.INS
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|
|
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
|
|
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
104
|
The cover page of Bed Bath & Beyond Inc.’s Quarterly Report on Form 10-Q for the quarter ended November 30, 2019, formatted in Inline XBRL (included within Exhibit 101 attachments)
|
|
*
|
This is a management contract or compensatory plan or arrangement.
|
|
**
|
Filed herewith.
|
|
|
|
BED BATH & BEYOND INC.
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
Date: January 9, 2020
|
|
By:
|
/s/ Robyn M. D'Elia
|
|
|
|
|
Robyn M. D'Elia
|
|
|
|
|
Chief Financial Officer and Treasurer
|
|
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Suppliers
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|